SANDRI, Gilda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.623
NA - Nord America 9.521
AS - Asia 6.218
SA - Sud America 848
Continente sconosciuto - Info sul continente non disponibili 207
AF - Africa 182
OC - Oceania 52
Totale 35.651
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.395
US - Stati Uniti d'America 9.227
SG - Singapore 1.781
CN - Cina 1.661
GB - Regno Unito 1.332
HK - Hong Kong 656
BR - Brasile 629
VN - Vietnam 620
NL - Olanda 554
DE - Germania 396
BD - Bangladesh 370
SE - Svezia 364
FR - Francia 336
FI - Finlandia 270
KR - Corea 237
RU - Federazione Russa 209
TR - Turchia 186
UA - Ucraina 180
CA - Canada 157
IN - India 149
ID - Indonesia 127
AR - Argentina 84
CH - Svizzera 82
ES - Italia 81
MX - Messico 80
JP - Giappone 79
BG - Bulgaria 62
IE - Irlanda 60
PL - Polonia 57
IQ - Iraq 53
ZA - Sudafrica 50
AU - Australia 45
AT - Austria 43
PK - Pakistan 37
MA - Marocco 34
BE - Belgio 33
CO - Colombia 31
MY - Malesia 31
PH - Filippine 26
AE - Emirati Arabi Uniti 25
EG - Egitto 23
NO - Norvegia 23
CZ - Repubblica Ceca 22
TW - Taiwan 22
CL - Cile 21
IR - Iran 21
EC - Ecuador 20
VE - Venezuela 20
PE - Perù 19
SA - Arabia Saudita 19
RO - Romania 17
GR - Grecia 15
KE - Kenya 15
LT - Lituania 14
AL - Albania 13
MT - Malta 13
NP - Nepal 12
PY - Paraguay 11
DZ - Algeria 10
IL - Israele 10
KZ - Kazakistan 10
TH - Thailandia 10
UZ - Uzbekistan 10
BH - Bahrain 9
BO - Bolivia 9
PT - Portogallo 9
TN - Tunisia 9
CR - Costa Rica 8
AZ - Azerbaigian 7
BZ - Belize 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
GT - Guatemala 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
OM - Oman 7
JO - Giordania 6
LV - Lettonia 6
BY - Bielorussia 5
KG - Kirghizistan 5
MK - Macedonia 5
PA - Panama 5
SN - Senegal 5
HN - Honduras 4
NG - Nigeria 4
NI - Nicaragua 4
RS - Serbia 4
SC - Seychelles 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AM - Armenia 3
CI - Costa d'Avorio 3
GE - Georgia 3
JM - Giamaica 3
KH - Cambogia 3
LB - Libano 3
MD - Moldavia 3
QA - Qatar 3
SI - Slovenia 3
AO - Angola 2
Totale 35.393
Salva come PNG Salva come JPEG
Città #
Rome 1.273
Santa Clara 1.250
Milan 1.160
Singapore 1.116
Ashburn 940
Southend 872
Hefei 655
Hong Kong 643
San Jose 636
Naples 476
Fairfield 428
Chandler 408
Bologna 357
Florence 329
Turin 301
Council Bluffs 260
Woodbridge 258
Jacksonville 255
Houston 252
London 248
Los Angeles 234
Seoul 224
Bari 219
Beijing 216
Ho Chi Minh City 208
Nyköping 199
Dearborn 197
Helsinki 189
Ann Arbor 180
Chicago 171
Wilmington 171
Modena 164
New York 163
The Dalles 156
Seattle 154
Catania 150
Parma 148
Genoa 143
Palermo 139
Hanoi 138
Cambridge 112
Verona 109
Brescia 92
Izmir 92
Jakarta 92
Buffalo 89
Lauterbourg 89
São Paulo 84
Moscow 83
Padova 83
Cagliari 80
Pescara 76
Reggio Emilia 73
Shanghai 72
Munich 71
Dallas 70
Princeton 67
San Diego 63
Orem 61
Salt Lake City 60
Trieste 59
Livorno 57
Sofia 57
Tokyo 55
Vicenza 52
Boardman 51
Trento 51
Rimini 49
Frankfurt am Main 47
Eugene 44
Mexico City 44
Toronto 42
Perugia 41
Tampa 40
Venice 36
Ancona 35
Bremen 35
Des Moines 35
Elk Grove Village 35
Da Nang 34
Kent 34
Amsterdam 32
Dublin 32
Monza 32
Redwood City 32
Taranto 32
Ottawa 31
Salerno 31
Treviso 31
Paris 30
Chennai 29
Messina 29
Bergamo 28
Falkenstein 28
Montreal 28
Ovada 28
Warsaw 28
Lucca 27
Stockholm 27
Valencia 27
Totale 18.793
Salva come PNG Salva come JPEG
Nome #
Farmaci biologici e rischio oncologico 4.687
Tempi di sospensione dei farmaci biologici nello switch terapeutico e nella programmazione degli interventi chirurgici 4.620
L’infezione da papilloma virus umano (HPV) nei pazienti con artrite reumatoide trattati con farmaci biologici 3.891
Farmaci biologici e infezione tubercolare 572
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 465
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 408
Biological Therapy and Risk of Malignancies: A Literature Review 361
Farmaci biologici e tematiche relative alla cardiopatia ischemica e all’insufficienza cardiaca 359
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 351
Cryoglobulin evaluation: analysis of intra-laboratory and inter-laboratory variability 350
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 341
Frequency and Results of Cryoglobulin Retesting in 4,963 Patients: Comment on the Article by Kolopp-Sarda et al 334
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 318
The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody status. 315
Non HCV-related mixed cryoglobulinemia 309
La legislazione del dolore e la sua applicazione in Italia: pregi e difetti 304
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 302
Early Occupational Therapy Intervention: Patients’ Occupational Needs 299
HCV associated cryoglobulinemic vasculitis 281
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 274
EULAR guidelines on ANCA-associated vasculitis in the real life 274
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 271
ANTI - TUMOR NECROSIS FACTOR ALPHA (ANTI-TNF) DRUGS IN RHEUMATOID ARTHRITIS: COMPARISON ON DISEASE MANAGEMENT BEFORE AND AFTER THE INTRODUCTION OF THESE BIOLOGICAL DRUGS IN MODENA, ITALY 269
Ultrasonography in the diagnosis and management of patients with inflammatory arthritides 267
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA): THE RELATIONSHIP BETWEEN SEX, AGE AND ANTIGENIC SPECIFICITIES 265
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 259
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 255
Le crioglobuline miste: epidemiologia, clinica ed eziopatogenesi. Contributo personale. 254
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 253
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 250
Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome 250
EXPERIMENTAL USE OF 3D PRINTING TECHNOLOGY FOR THE CONSTRUCTION OF DEVICES AS INTEGRATION OF OCCUPATIONAL THERAPY INTERVENTION WITH RHEUMATOID ARTHRITIS PATIENTS (RA) 248
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 246
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre 246
Salivary 1H-NMR Metabolomics in Primary Sjögren Syndrome. Preliminary Results of a Pilot Case-Control Study 243
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 242
Non-Hodgkin Lymphoma in Psoriatic Arthritis Treated with Sequential, Multiple Anti-TNF-α Agents: A Case Report 241
Sanitary costs of osteoarthritis 239
L’uso dei farmaci biologici durante la gravidanza e l’allattamento 239
Metabolic Profile of Whole Unstimulated Saliva in Patients with Sjögren's Syndrome 231
NATURAL HISTORY OF CRYOGLOBULINEMIA FROM 2000 TO 2018 FROM THE LABORATORY POINT OF VIEW: AN ANALYSIS OF CRYOGLOBULIN CHARACTERISTICS IN A SINGLE CENTER. 230
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 229
Risankizumab e Upadacitinib nel Trattamento dell'Artrite Psoriasica: Meccanismi Diversi, Obiettivo Comune 229
Apremilast retention rate in clinical practice: observations from an Italian multi-center study 227
PREVALENCE OF ULTRASOUND ABNORMALITIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN A CLINICAL PHASE OF MINIMAL DISEASE ACTIVITY UNDER ANTI-TNF TREATMENT 225
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 220
Indicazioni chirurgiche alla artrodesi totale di polso nei pazienti affetti da artrite reumatoide. 218
Farmaci biologici ed epatiti da virus B e C 213
On- and off-label use of rituximab in rheumatic diseases 213
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 211
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 210
UTILITY OF A SELF ADMINISTERED QUESTIONNAIRE AS A TOOL FOR SCREENING JOINT INVOLVEMENT UNDERWAY PSORIASIS 209
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 209
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 207
EXPERIENCE OF MULTIDISCIPLINARY TEAM FOR COMPLEX HAND FUNCTION PROBLEMS AT THE RHEUMATOLOGY OUTPATIENT CLINIC OF MODENA 205
Endothelial Dysfunction in Acute Hepatic Porphyrias 204
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 198
Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients 198
Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis 196
Efficacia e sicurezza delle vaccinazioni anti-influenza e anti-pneumococco nei pazienti con artrite reumatoide trattati con farmaci biologici 194
The New Test for Monitoring Infliximab Therapy: From Laboratory to Clinical Practice 191
Ultrasonographic and clinical assessment of peripheral enthesitis and arthritis in an Italian cohort of inflammatory bowel disease patients 188
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 188
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 187
Patient characteristics of HCV-negative mixed cryoglobulinemia (MC) in Italy and Holland 182
Diagnosi di crioproteinemia: preziosa collaborazione tra laboratorio e clinica per la corretta gestione di una patologia rara 179
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 178
Cryofibrinogen: A possibile risk factor in systemic sclerosis 177
A CALL FOR A COMPREHENSIVE ROLE DEFINITION OF THE STUDY COORDINATOR IN RHEUMATOLOGICAL CLINICAL STUDIES 175
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic review 174
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population 172
Cryoproteinemia: new frontiers for clinicians and the laboratory 172
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 170
IS THERE A DISSOCIATION BETWEEN CLINICAL REMISSION AND ULTRASONOGRAPHIC ASSESSMENT IN RHEUMATOID ARTHRITIS? 167
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 166
Role of COVID-19 in the progression of scleroderma interstitial lung disease and new onset pulmonary hypertension: a challenging case report. 163
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 159
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients 159
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 158
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 157
Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study. 153
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 152
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project 148
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 146
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 146
Secondary cryofbrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study 144
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 144
The management of large vessel vasculitides 142
SAFETY AND EFFICACY OF INTRAVENOUS ILOPROST IN THE TREATMENT AND PREVENTION OF SCLERODERMA-RELATED DIGITAL ULCERS 141
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 33, 7, (1398-1409), 10.1038/s41379-020-0497-0) 140
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritis 135
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 133
Upadacitinib: One More Option in the Treatment of Patients with Rheumatoid Arthritis and Crohn's Disease 130
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 129
Buerger's disease or thromboangiitis obliterans: description of two cases 121
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 120
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup— AMulticenter Study 119
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 115
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study 108
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 108
Totale 34.564
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.349 0 123 69 109 54 90 59 87 212 72 277 197
2022/20232.719 184 186 171 161 194 293 152 259 313 177 312 317
2023/20245.535 318 249 393 460 512 413 562 550 273 595 618 592
2024/20259.128 570 415 411 676 1.509 1.064 685 627 1.009 559 794 809
2025/202611.424 832 616 1.051 1.492 1.377 693 1.256 594 958 951 894 710
2026/2027695 498 197 0 0 0 0 0 0 0 0 0 0
Totale 35.651